These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16236530)

  • 1. Toxicogenomic analysis methods for predictive toxicology.
    Maggioli J; Hoover A; Weng L
    J Pharmacol Toxicol Methods; 2006; 53(1):31-7. PubMed ID: 16236530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a toxicogenomics in vitro assay for the efficient characterization of compounds.
    Yang Y; Abel SJ; Ciurlionis R; Waring JF
    Pharmacogenomics; 2006 Mar; 7(2):177-86. PubMed ID: 16515397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
    Youns M; Hoheisel JD; Efferth T
    Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of new technologies to characterization and prediction of adverse effects.
    Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
    Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships.
    Liu Z; Kelly R; Fang H; Ding D; Tong W
    Chem Res Toxicol; 2011 Jul; 24(7):1062-70. PubMed ID: 21627106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicogenomics in the assessment of immunotoxicity.
    Baken KA; Vandebriel RJ; Pennings JL; Kleinjans JC; van Loveren H
    Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTNI: a novel toxicogenomics data analysis tool for identifying the molecular mechanisms underlying the adverse effects of toxic compounds.
    Hendrickx DM; Souza T; Jennen DGJ; Kleinjans JCS
    Arch Toxicol; 2017 Jun; 91(6):2343-2352. PubMed ID: 28032149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database.
    Ganter B; Snyder RD; Halbert DN; Lee MD
    Pharmacogenomics; 2006 Oct; 7(7):1025-44. PubMed ID: 17054413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicogenomics and systems toxicology: aims and prospects.
    Waters MD; Fostel JM
    Nat Rev Genet; 2004 Dec; 5(12):936-48. PubMed ID: 15573125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping molecular responses to xenoestrogens through Gene Ontology and pathway analysis of toxicogenomic data.
    Currie RA; Orphanides G; Moggs JG
    Reprod Toxicol; 2005; 20(3):433-40. PubMed ID: 15964738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of toxicogenomic approaches in developmental toxicology.
    Robinson JF; Pennings JL; Piersma AH
    Methods Mol Biol; 2012; 889():347-71. PubMed ID: 22669676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an in vitro liver toxicity prediction model based on longer term primary rat hepatocyte culture.
    Hrach J; Mueller SO; Hewitt P
    Toxicol Lett; 2011 Oct; 206(2):189-96. PubMed ID: 21807079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
    Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
    Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional profiling of reactive metabolites for elucidating toxicological mechanisms: a case study of quinoneimine-forming agents.
    Stamper BD
    Drug Metab Rev; 2015 Feb; 47(1):45-55. PubMed ID: 25351209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
    Gatzidou ET; Zira AN; Theocharis SE
    J Appl Toxicol; 2007; 27(4):302-9. PubMed ID: 17429800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of microarray-based analysis of gene expression in the field of toxicogenomics.
    Mei N; Fuscoe JC; Lobenhofer EK; Guo L
    Methods Mol Biol; 2010; 597():227-41. PubMed ID: 20013237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SimuGen Ltd: reliable, early prediction of drug toxicity with toxicogenomics, human cell culture and computational models.
    Wills Q
    Pharmacogenomics; 2007 Aug; 8(8):1081-4. PubMed ID: 17716240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literature-based compound profiling: application to toxicogenomics.
    Frijters R; Verhoeven S; Alkema W; van Schaik R; Polman J
    Pharmacogenomics; 2007 Nov; 8(11):1521-34. PubMed ID: 18034617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.